Upgrade to SI Premium - Free Trial

Tonix Pharmaceuticals (TNXP) Reports Q3 Loss of $0.29/Share

November 10, 2016 4:32 PM

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q3 EPS of ($0.29), versus ($0.72) reported last year.

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

Categories

Earnings

Next Articles